Interaction between Na+/phosphate-cotransporter and the adrenoceptors in myocardial depression

J Cardiovasc Pharmacol. 1998 Jan;31(1):10-7. doi: 10.1097/00005344-199801000-00002.

Abstract

The primary objective of this study was to test the hypothesis that an increase in the alpha1-adrenoceptor tone would potentiate the myocardial biphasic contractile response to inorganic phosphate [Pi, the substrate of Na/Pi-cotransporter (NP)]. A second aim was to determine whether activation of alpha1-adrenoceptor is necessary for the NP-mediated increase in myocardial contractility (+dP/dt). Earlier study from this laboratory showed that high concentration of Pi (10 mM) produces a biphasic contractile response: initial increase in +dP/dt was followed by decline. In another study, Pi (3.5 mM) potentiated phenylephrine (PHE)-induced increase in +dP/dt. The alpha1-adrenoceptor was not blocked in these studies, and it can still be activated by the electrical stimulation of the sympathetic nerve terminals to the heart. Additionally, alpha1-adrenoceptor-activated increases in the activity of NP have been reported in numerous studies in noncardiac tissues and cell lines; therefore it is not clear whether Pi-induced increase in +dP/dt occurs only in the presence of alpha1-adrenoceptor activation. This study was performed by using isolated perfused rat heart in the condition of controlled extracellular calcium activity (0.72 mM); fixed preload (15 mm Hg); and constant heart rate (280 beats/min) and coronary flow (8 ml/min). The electronically differentiated value of the left ventricular pressure (LVP) signal was used as an index of myocardial contractility. The data show that activation of the alpha1-adrenoceptor is not necessary for the Pi-induced increase in +dP/dt (i.e., NP-mediated increase in +dP/dt has both the alpha1-adrenoceptor-dependent and alpha1-adrenoceptor-independent components. The interaction between alpha1-adrenoceptor agonist (PHE) and Pi (10 mM) did not produce a biphasic myocardial contractile response in the presence of propranolol. Because our earlier data on myocardial biphasic contractile response to 10 mM Pi was obtained when neither the beta- nor the alpha-adrenoceptor was blocked, we carried out more studies to see whether beta-adrenoceptor plays a role in this Pi-induced biphasic response. When both the alpha- and beta-adrenoceptors were activated with norepinephrine (NE), myocardial depression by high Pi concentration was markedly potentiated. This myocardial depression did not occur in the presence of phosphonoformate, a selective inhibitor of NP. It also did not occur when alpha1-adrenoceptor was blocked. Our data suggest that alpha1- and beta-adrenoceptors do not interact with the cardiac NP to potentiate the Pi-induced biphasic contractile response, but they interact in a manner that potentiates Pi-induced myocardial depression.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Cardiotonic Agents / pharmacology*
  • Carrier Proteins / drug effects*
  • Carrier Proteins / physiology
  • Depression, Chemical
  • Drug Interactions
  • Male
  • Myocardial Contraction / drug effects*
  • Norepinephrine / pharmacology
  • Propranolol / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha / drug effects*
  • Receptors, Adrenergic, alpha / metabolism
  • Receptors, Adrenergic, beta / drug effects*
  • Receptors, Adrenergic, beta / metabolism
  • Sodium-Phosphate Cotransporter Proteins
  • Symporters*

Substances

  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Antagonists
  • Cardiotonic Agents
  • Carrier Proteins
  • Receptors, Adrenergic, alpha
  • Receptors, Adrenergic, beta
  • Sodium-Phosphate Cotransporter Proteins
  • Symporters
  • Propranolol
  • Norepinephrine